In the context of neurodegenerative diseases, and dementia in particular, extensive analyses have shown that APOE genotype influences cognitive and non-cognitive phenotypes of subjects with a clinical diagnosis of MCI or AD (clinically probable AD). Here, APOE is linked to neurodegenerative disease.